Amanote Research
Register
Sign In
C3b Inactivator in the Rheumatic Diseases. Measurement by Radial Immunodiffusion and by Inhibition of Formation of Properdin Pathway C3 Convertase.
Journal of Clinical Investigation
- United States
doi 10.1172/jci108426
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Date
June 1, 1976
Authors
K Whaley
P H Schur
S Ruddy
Publisher
American Society for Clinical Investigation
Related search
Inactivator of the Third Component of Complement as an Inhibitor in the Properdin Pathway
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Functional Characterization of Alternative and Classical Pathway C3/C5 Convertase Activity and Inhibition Using Purified Models
Frontiers in Immunology
Allergy
Immunology
The Role of Properdin in the Assembly of the Alternative Pathway C3 Convertases of Complement
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Purification of the Human Complement Control Protein C3b Inactivator
Biochemical Journal
Biochemistry
Cell Biology
Molecular Biology
Covalent Association of C3b With C4b Within C5 Convertase of the Classical Complement Pathway
Journal of Experimental Medicine
Medicine
Allergy
Immunology
Insights Into the Effects of Complement Factor H on the Assembly and Decay of the Alternative Pathway C3 Proconvertase and C3 Convertase.
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
TWO DIFFERENT COMPLEMENT RECEPTORS ON HUMAN LYMPHOCYTES: ONE SPECIFIC FOR C3b AND ONE SPECIFIC FOR C3b INACTIVATOR-CLEAVED C3b
Journal of Experimental Medicine
Medicine
Allergy
Immunology
Thyroglobulin Determined in Thyroid Fine Needle Aspiration Biopsies by Radial Immunodiffusion and Electroimmunodiffusion
Clinical Chemistry and Laboratory Medicine
Biochemistry
Medicine
Clinical Biochemistry
Chemotactic Activity Derived From Interaction of Factors D and B of the Properdin Pathway With Cobra Venom Factor or C3B.
Journal of Clinical Investigation
Medicine